| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| Altrenogest Impurity C |
烯丙孕素雜質(zhì)C |
4642-95-9 |
詳細(xì)
|
| Parecoxib Impurity B |
帕瑞昔布鈉雜質(zhì)B對照品 |
198471-06-6 |
詳細(xì)
|
| 4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butan-1-ol |
4-(4-(苯并[b]噻吩-4-基)哌嗪-1-基)丁醇 |
913614-15-0 |
詳細(xì)
|
| Tetraethyl naphthoquinone impurity SM2-2 |
四烯甲萘醌雜質(zhì)SM2-2 |
1117-52-8 |
詳細(xì)
|
| Altrenogest Impurity A |
烯丙孕素雜質(zhì)A |
141299-96-9 |
詳細(xì)
|
| S-3,3'-Bis(2,4,6-triisopropylphenyl)-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate |
(S)-3,3'-雙(2,4,6-三異丙基苯基)-1,1'-二-2-茶酚環(huán)-磷酸酯 |
874948-63-7 |
詳細(xì)
|
| 4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid 3-methyl 5-(1-methylethyl) ester |
4-(2,3- 二氯苯基)-1,4-二氫-2,6-二甲基-3,5-吡啶二甲酸3-甲基-5-(1-甲基乙基)酯 |
74073-24-8 |
詳細(xì)
|
| Ethyl drunicosapentaenoenylate |
二十一碳五烯酸乙酯 |
131775-86-5 |
詳細(xì)
|
| Etoricoxib dechlorinated impurities |
依托考昔去氯雜質(zhì) |
1350206-14-2 |
詳細(xì)
|
| 2-(2-(2,6-dichlorophenyl)(nitroso)amino)phenyl)propanoate |
2-(2-(2,6-二氯苯基)(亞硝基)氨基)苯基)乙酸異丙酯 |
66370-79-4 |
詳細(xì)
|
| 1-(4-nitrophenoxy)propan-2-one |
1-(4-硝基苯氧基)丙-2-酮 |
6698-72-2 |
詳細(xì)
|
|
(3,5-二氯-4-羥基苯基)(3(2H)-苯并噻唑基)甲酮 |
1285572-54-4 |
詳細(xì)
|
| 1-phenylpyridin-1-ium chloride |
1-苯基吡啶-1-氯化銨 |
13958-90-2 |
詳細(xì)
|
| 3,5-Bis(1-methylethyl) 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate |
3,5-吡啶二甲酸，4-（2,3-二氯苯基）-1,4-二氫-2,6-二甲基-3,5-雙（1-甲基乙基）酯 |
110962-86-2 |
詳細(xì)
|
|
核黃素磷酸鈉EP雜質(zhì)A |
86108-27-2 |
詳細(xì)
|
|
1-乙基-2-羥甲基吡咯烷 |
3433-34-9 |
詳細(xì)
|
| 2,3-Dimethoxy-5-methyl-1,4-hydroquinone |
2,3-二甲氧基-5-甲基苯-1,4-二醇（雜質(zhì)A） |
3066-90-8 |
詳細(xì)
|
|
核黃素磷酸鈉EP雜質(zhì)C |
86108-25-0 |
詳細(xì)
|
| IMP-6 |
IMP-6 |
|
詳細(xì)
|
| 3α,12β-Dihydroxycholanoic Acid |
3α,12β-羥基膽烷酸 |
570-62-7 |
詳細(xì)
|
|
非奈利酮亞硝胺雜質(zhì) |
|
詳細(xì)
|
| Camphor |
樟腦 |
21368-68-3 |
詳細(xì)
|
|
西他沙星雜質(zhì)XT-D-SR |
127199-26-2 |
詳細(xì)
|
| Parecoxib Impurity C |
帕瑞昔布鈉雜質(zhì)C |
1709956-89-7 |
詳細(xì)
|
| Methotrexate Impurity A |
甲氨蝶呤雜質(zhì)A |
945-24-4 |
詳細(xì)
|
| (2R, 5R) -benzyloxyaminopiperidine-2-carboxylic acid ethyl sulfate salt |
(2R,5R)-5-((芐氧基)氨基)哌啶-2-羧酸乙酯硫酸鹽 |
2089462-91-7 |
詳細(xì)
|
| Lamivudine Dimer |
拉米夫定二聚體 |
|
詳細(xì)
|
| Reduced Coenzyme Q10 |
還原型輔酶Q10 |
992-78-9 |
詳細(xì)
|
| (+)-Borneol |
右莰醇 |
464-43-7 |
詳細(xì)
|
| Methotrexate Impurity L |
甲氨蝶呤雜質(zhì)L |
52980-68-4 |
詳細(xì)
|
|
鹽酸依匹斯汀雜質(zhì)C對 |
1216548-20-7 |
詳細(xì)
|
| Itratimod arginine impurity SM3-3 |
伊曲莫德精氨酸雜質(zhì)SM3-3 |
1206125-14-5 |
詳細(xì)
|
| Cimetidine Impurity F |
西咪替丁雜質(zhì)F |
55272-86-1 |
詳細(xì)
|
| Standard product of Oseltamivir phosphate intermediate S001P02 |
磷酸奧司他韋中間體S001P02標(biāo)準(zhǔn)品 |
312904-18-0 |
詳細(xì)
|
| Furfural acetate |
糠醛乙酸酯 |
613-75-2 |
詳細(xì)
|
| Epinastine Impurity A024-V |
依匹斯汀雜質(zhì)A024-V對照品 |
127785-96-0 |
詳細(xì)
|
| Fmoc-Thr(tBu)-Phe-Phe-OH |
Fmoc-Thr(tBu)-Phe-Phe-OH |
|
詳細(xì)
|
| Methotrexate Impurity H |
甲氨蝶呤雜質(zhì)H |
67022-39-3 |
詳細(xì)
|
| Vortioxetine Impurity 31 |
沃替西汀雜質(zhì)31 |
2135576-73-5 |
詳細(xì)
|
| Rosuvastatin calcium intermediate I diastereoisomer |
瑞舒伐他汀鈣中間體I非對映異構(gòu)體 |
1379976-09-6 |
詳細(xì)
|
|
林可霉素EP雜質(zhì)C對照品 |
14600-41-0 |
詳細(xì)
|
| Linagliptin Impurity 17 |
利格列汀雜質(zhì)17 |
2489212-72-6 |
詳細(xì)
|
| Dronedarone hydrochloride impurity SM1-16 |
鹽酸決奈達(dá)隆雜質(zhì)SM1-16 |
2540665-66-3 |
詳細(xì)
|
| GVNE |
GVNE |
|
詳細(xì)
|
| Calcium disodium edetate dihydrate |
乙二胺四醋酸鈣二鈉對照品 |
23411-34-9 |
詳細(xì)
|
| Olmesartan Ethyl Ester Trityl Impurity |
三苯甲基奧美沙坦乙酯 |
144690-33-5 |
詳細(xì)
|
|
阿維巴坦雜質(zhì)1 |
2243810-78-6 |
詳細(xì)
|
| Aprocitentan Impurity SM1-10 |
阿普昔騰坦雜質(zhì)SM1-10 |
674-81-7 |
詳細(xì)
|
| 8-Fluoro-3,4-Dihydro-1H Quinolin-2-One |
8-氟-3,4-氫-1H-喹啉-2-酮 |
143268-79-5 |
詳細(xì)
|
| Itratimod arginine impurity SM2-1 |
伊曲莫德精氨酸雜質(zhì)SM2-1 |
100-02-7 |
詳細(xì)
|
| Aprocitentan Impurity SM1-9 |
阿普昔騰坦雜質(zhì)SM1-9 |
885702-34-1 |
詳細(xì)
|
| 3-[4-(Heptyloxy)-1,2,5-thiadiazole-3-yl]-1-methylpyridinium iodide |
3-[4-(庚基氧基)-1,2,5-硫雜二氮雜環(huán)戊熳-3-基]-1-甲基吡啶-1-正離子 碘離子 |
|
詳細(xì)
|
| Budesonide Impurity K |
布地奈德雜質(zhì)K |
51333-05-2 |
詳細(xì)
|
| Montelukast Dicyclohexylamine Salt |
孟魯司特二環(huán)己胺對照品 |
577953-88-9 |
詳細(xì)
|
| 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-carboxylic acid |
三苯甲基奧美沙坦（4-（1-羥基-1-甲基乙基）-2-丙基-1-[[2′-（1-三苯甲基-1H-四唑-5-基）[1,1′-聯(lián)苯基]-4-基]甲基]-1H-咪唑-5-羧酸）對照品 |
761404-85-7 |
詳細(xì)
|
| Etocoxinaphthalene ring impurity |
依托考昔萘環(huán)雜質(zhì) |
646459-41-8 |
詳細(xì)
|
| 8-fluoro-3,4-dihydroisoquinolin-1(2H)-one |
8-氟-3,4-二氫-2H-異喹啉-1-酮 |
1368930-77-1 |
詳細(xì)
|
|
核黃素磷酸鈉EP雜質(zhì)B |
86108-26-1 |
詳細(xì)
|
| Budesonide Impurity L |
布地奈德雜質(zhì)L |
216453-74-6 |
詳細(xì)
|
|
3-(3,5-二氯-4-羥基苯甲?；?-1-氧代-2,3-二氫-1,3-苯并噻唑 |
1285572-55-5 |
詳細(xì)
|
| Fatty acid methyl ester |
混合脂肪酸甲酯 |
67762-38-3 |
詳細(xì)
|
| 1,3-Bis(carboxymethyl)-1H-imidazolium |
1,3-雙(羧甲基)-1H-咪唑 |
117255-11-5 |
詳細(xì)
|
| Ruxolitinib INT2-A |
蘆可替尼INT2-A |
|
詳細(xì)
|
| (2,2-dichloroacetyl)-L-glutamine |
2,2-二氯乙?；?L-谷氨酰胺 |
|
詳細(xì)
|
| 3-Phenyl-4-isoxazole carboxylchloric anhydride |
3-苯基-4-異惡唑甲酰氯酸酐 |
16883-18-4 |
詳細(xì)
|
| 3-Amino-2-hydroxypyridine |
3-氨基-2-羥基吡啶 |
59315-44-5 |
詳細(xì)
|
| Torsemide Impurity E |
托拉塞米雜質(zhì)E |
|
詳細(xì)
|
| Budesonide intermediate II. Impurity H |
布地奈德中間體Ⅱ雜質(zhì)H |
|
詳細(xì)
|
| Standard substance of Oseltamivir phosphate intermediate S001M6P30 |
磷酸奧司他韋中間體S001M6P30標(biāo)準(zhǔn)品 |
2918995-63-6 |
詳細(xì)
|
| Nicardipine N-oxide |
尼卡地平 N-氧化物 |
2724510-66-9 |
詳細(xì)
|
| Ethyl 5-methyl-3-phenylisoxazole-4-carboxylate |
5-甲基-3-苯基異惡唑-4-羧酸乙酯 |
1143-82-4 |
詳細(xì)
|
|
氯維地平亞硝基雜質(zhì) |
|
詳細(xì)
|
| 4-(1-(2-hydroxyethyl)-1H-benzimidazole-2-yl)piperidine-1-carboxylic acid tert-butyl ester |
4-(1-(2-羥乙基)-1H-苯并咪唑-2-基)哌啶-1-羧酸叔丁酯 |
|
詳細(xì)
|
| Fmoc-Thr(tBu)-D-Phe-OH |
Fmoc-Thr(tBu)-D-Phe-OH |
|
詳細(xì)
|
| Cimetidine Impurity G |
西咪替丁雜質(zhì)G對照品 |
31857-31-5 |
詳細(xì)
|
| Methotrexate Impurity G |
甲氨蝶呤雜質(zhì)G |
2519848-42-9 |
詳細(xì)
|
| 2-((2-((5-nitrofuryl)-methylene)hydrazinyl)ethyl)-1-alcohol |
2-（2-（（5-硝基呋喃-2-基）亞甲基）酰肼基）乙烷-1-醇 |
13641-86-6 |
詳細(xì)
|
| Avibactam Impurity 30 |
阿維巴坦鈉雜質(zhì)30 |
1463501-46-3 |
詳細(xì)
|
|
N-去甲基-N-亞硝胺克拉霉素對照品 |
|
詳細(xì)
|
| 6-Fluoro-3,4-dihydroquinolin-2(1H)-one |
6-氟-3,4-二氫喹啉-2(1H)-酮 |
75893-82-2 |
詳細(xì)
|
| N-Nitroso Apixaban Amino Acid Impurity |
N-亞硝基阿哌沙班氨基酸雜質(zhì) |
|
詳細(xì)
|
| 5-Demethoxy Coenzyme Q10 |
5-脫甲氧基輔酶Q10 |
2006296-15-5 |
詳細(xì)
|
| Dronedarone hydrochloride impurity SM1-14 |
鹽酸決奈達(dá)隆雜質(zhì)SM1-14 |
98873-72-4 |
詳細(xì)
|
| (2S, 5S) -benzyloxyaminopiperidine-2-carboxylic acid ethyl sulfate salt |
(2S,5S)-5-[(芐基氧基)氨基]哌啶-2-甲酸乙酯草酸鹽 |
2085372-14-9 |
詳細(xì)
|
| Standard substance of Oseltamivir phosphate intermediate S001M7P38 |
磷酸奧司他韋中間體S001M7P38標(biāo)準(zhǔn)品 |
|
詳細(xì)
|
| Ruxolitinib INT3-F |
蘆可替尼INT3-F |
|
詳細(xì)
|
| Cefdinir Impurity 40 |
頭孢地尼雜質(zhì)40 |
1330164-22-1 |
詳細(xì)
|
| IMP-3 |
|
209551-67-7 |
詳細(xì)
|
| Celecoxib Impurity D |
塞來昔布雜質(zhì)D |
1061214-06-9 |
詳細(xì)
|
| 4-(1-(2-(2-chloroethoxy)ethyl)-1H-benzimidazol-2-yl)piperidine-1-carboxylic acid tert-butyl ester |
4-(1-(2-(2-氯乙氧基)乙基)-1H-苯并咪唑-2-基)哌啶-1-羧酸叔丁酯 |
|
詳細(xì)
|
| Promethazine EP Impurity B |
鹽酸異丙嗪雜質(zhì)B對照品 |
303-14-0 |
詳細(xì)
|
| Mabaloxavir isomer impurity 3 |
瑪巴洛沙韋異構(gòu)體雜質(zhì)3 |
|
詳細(xì)
|
| Epinastine Impurity C |
鹽酸依匹斯汀雜質(zhì)C對照品 |
775350-99-7 |
詳細(xì)
|
| Fmoc-D-Thr(tBu)-Phe-OH |
Fmoc-D-Thr(tBu)-Phe-OH |
|
詳細(xì)
|
| Ilaprazole APLZ-IM-019 |
艾普拉唑APLZ-IM-019 |
|
詳細(xì)
|
| Murideoxycholic Acid |
鼠脫氧膽酸 |
668-49-5 |
詳細(xì)
|
|
普羅帕酮USP相關(guān)物質(zhì)A |
|
詳細(xì)
|
| Fmoc-β-Ala-Gly-Gly-OH |
Fmoc-β-Ala-Gly-Gly-OH |
|
詳細(xì)
|
| Bradyneo impurity 14 |
布拉地新雜質(zhì)14 |
|
詳細(xì)
|
| Acetamide-N-sulfonate triethylammonium |
乙酰乙酰胺-N-磺酸三乙銨 |
99911-48-5 |
詳細(xì)
|